Back to Search
DR. JAE H. KIM M.D.
M.D.
Gastroenterology Physician
NPI: 1861578759Individual
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
73759(AZ)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.
PMID 39978685·J Allergy Clin Immunol·2025
8-other
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment.
PMID 28927890·J Invest Dermatol·2018
3-trial
Proportion of CD4CD49bLAG-3Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index.
PMID 29890167·J Invest Dermatol·2018
8-other
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
PMID 30097359·Lancet·2018
3-trial
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.
PMID 27686018·Annu Rev Med·2017
6-review
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
PMID 28423301·N Engl J Med·2017
3-trial
Patients With Psoriasis and Personalized Trade-offs in Treatment Decisions-Lessons Learned From Focus Groups.
PMID 27028481·JAMA Dermatol·2016
8-other
Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.
PMID 26763436·J Invest Dermatol·2016
4-observational
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
PMID 27185339·J Invest Dermatol·2016
4-observational
Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial.
PMID 25769911·J Allergy Clin Immunol·2015
2-rct
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.
PMID 14707118·J Exp Med·2004
4-observational
Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women.
PMID 19543507·J Korean Med Sci·2009
8-other
A breathing wormlike chain model on DNA denaturation and bubble: effects of stacking interactions.
PMID 18266461·J Chem Phys·2008
8-other
Residential traffic and children's respiratory health.
PMID 18795175·Environ Health Perspect·2008
8-other
Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women.
PMID 17482599·Fertil Steril·2008
8-other
Facile preparative route to alkanethiolate-coated Au38 nanoparticles: postsynthesis core size evolution.
PMID 17542625·Langmuir·2007
8-other
Size-controlled interparticle charge transfer between TiO2 and quantized capacitors.
PMID 17547402·J Am Chem Soc·2007
8-other
Electron hopping dynamics in Au38 nanoparticle langmuir monolayers at the air/water interface.
PMID 16594657·J Am Chem Soc·2006
8-other
Suppression of quantum scattering in strongly confined systems.
PMID 17155625·Phys Rev Lett·2006
8-other
Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women.
PMID 16369899·J Bone Miner Metab·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via THE GROUP GASTRO, LLC · 4 locations total
- Address
- 10238 E HAMPTON AVE STE 205
MESA, AZ 85209 - Phone
- (480) 856-8252
Locations (4)
Quick Facts
- NPI
- 1861578759
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 4
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile